Q4 2015 Stericycle Recall Index cites influx of drugs entering market and mergers and acquisitions as factors. Stericycle ExpertSOLUTIONS™ released the findings of its Q4 2015 Stericycle Recall Index. The report highlighted the complexities surrounding the pharmaceutical industry, especially as it pertains to counterfeit drugs, mergers and acquisitions (M&A), and regulatory shifts. The Q4 Index noted…